139 related articles for article (PubMed ID: 25443667)
1. Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes.
Shterzer N; Heyman D; Shapiro B; Yaniv A; Jackman A; Serour F; Chaouat M; Gonen P; Tommasino M; Sherman L
Virology; 2014 Nov; 468-470():647-659. PubMed ID: 25443667
[TBL] [Abstract][Full Text] [Related]
2. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
Pacini L; Ceraolo MG; Venuti A; Melita G; Hasan UA; Accardi R; Tommasino M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724760
[TBL] [Abstract][Full Text] [Related]
3. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.
Underbrink MP; Howie HL; Bedard KM; Koop JI; Galloway DA
J Virol; 2008 Nov; 82(21):10408-17. PubMed ID: 18715924
[TBL] [Abstract][Full Text] [Related]
4. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes.
Struijk L; van der Meijden E; Kazem S; Ter Schegget J; de Gruijl FR; Steenbergen RDM; Feltkamp MCW
J Gen Virol; 2008 Sep; 89(Pt 9):2303-2314. PubMed ID: 18753241
[TBL] [Abstract][Full Text] [Related]
5. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.
Caldeira S; Zehbe I; Accardi R; Malanchi I; Dong W; Giarrè M; de Villiers EM; Filotico R; Boukamp P; Tommasino M
J Virol; 2003 Feb; 77(3):2195-206. PubMed ID: 12525654
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous HPV and skin cancer.
Accardi R; Gheit T
Presse Med; 2014 Dec; 43(12 Pt 2):e435-43. PubMed ID: 25451638
[TBL] [Abstract][Full Text] [Related]
7. E6 proteins of α and β cutaneous HPV types differ in their ability to potentiate Wnt signaling.
Sominsky S; Shterzer N; Jackman A; Shapiro B; Yaniv A; Sherman L
Virology; 2017 Sep; 509():11-22. PubMed ID: 28586650
[TBL] [Abstract][Full Text] [Related]
8. E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity.
Habig M; Smola H; Dole VS; Derynck R; Pfister H; Smola-Hess S
Arch Virol; 2006 Oct; 151(10):1961-72. PubMed ID: 16710631
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes.
Alfandari J; Shnitman Magal S; Jackman A; Schlegel R; Gonen P; Sherman L
Virology; 1999 May; 257(2):383-96. PubMed ID: 10329549
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
11. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
Dacus D; Cotton C; McCallister TX; Wallace NA
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
[TBL] [Abstract][Full Text] [Related]
12. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes.
Akgül B; Lemme W; García-Escudero R; Storey A; Pfister HJ
Arch Virol; 2005 Jan; 150(1):145-51. PubMed ID: 15654507
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
15. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients.
de Villiers EM; Lavergne D; McLaren K; Benton EC
Int J Cancer; 1997 Nov; 73(3):356-61. PubMed ID: 9359482
[TBL] [Abstract][Full Text] [Related]
16. Papillomaviruses in human cancers.
zur Hausen H
Proc Assoc Am Physicians; 1999; 111(6):581-7. PubMed ID: 10591087
[TBL] [Abstract][Full Text] [Related]
17. Transforming properties of ovine papillomaviruses E6 and E7 oncogenes.
Tore G; Dore GM; Cacciotto C; Accardi R; Anfossi AG; Bogliolo L; Pittau M; Pirino S; Cubeddu T; Tommasino M; Alberti A
Vet Microbiol; 2019 Mar; 230():14-22. PubMed ID: 30827380
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types.
de Koning MN; ter Schegget J; Eekhof JA; Kamp M; Kleter B; Gussekloo J; Feltkamp MC; Bouwes Bavinck JN; Purdie KJ; Bunker CB; Proby CM; Meys R; Harwood CA; Quint WG
J Clin Microbiol; 2010 May; 48(5):1706-11. PubMed ID: 20237103
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
[TBL] [Abstract][Full Text] [Related]
20. The low-risk papillomaviruses.
Egawa N; Doorbar J
Virus Res; 2017 Mar; 231():119-127. PubMed ID: 28040475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
